Dogwood Therapeutics, Inc. Common Stock
Symbol: DWTX (NASDAQ)
4.86
▲ (0.52%) 0.025
Company Description:
Dogwood Therapeutics Inc, formerly Virios Therapeutics Inc, is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a virus-triggered abnormal immune response, such as fibromyalgia (FM) and long COVID (LC). Its product candidates include IMC-1 and IMC-2. IMC-1 is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.
Key Stats
- Today's Open: $4.79
- Today's High: $4.935
- Today's Low: $4.79
- Today's Volume: 7.70K
- Yesterday Close: $4.83
- Yesterday High: $4.9155
- Yesterday Low: $4.77
- Yesterday Volume: 5.41K
- Last Min Volume: 4
- Last Min High: $4.855
- Last Min Low: $4.855
- Last Min VWAP: $4.855
Company Profile
- Name: Dogwood Therapeutics, Inc. Common Stock
- Website: https://www.virios.com
- Listed Date: 2020-12-17
- Location: ALPHARETTA, GA
- Market Status: Active
- CIK Number: 0001818844
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $9.36M
- Round Lot: 100
- Outstanding Shares: 1.91M
- Asset Type: CS
RECENT FILINGS FOR DWTX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-13 | 10-Q | View |
| 2025-08-13 | 8-K | View |
| 2025-07-02 | 8-K | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-06-26 | S-8 | View |
| 2025-06-24 | 8-K | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-02 | EFFECT | View |
| 2025-05-29 | CORRESP | View |
| 2025-05-28 | UPLOAD | View |
Latest News on DWTX